We provide our excellent experiences to our customer
Flow Cytometer
Flow Cytometer >ACEA > Flow Cytometer
 
Novo Cyte Quanteon

¡Ø °í°´´ÔÀÇ ¸ð´ÏÅÍ Çػ󵵿¡ µû¶ó »óÇ°»ö»óÀÌ Á¶±Ý¾¿ ´Þ¶óÁú ¼ö ÀÖ½À´Ï´Ù.
Novo Cyte Quanteon
  
   ÆäÀ̽ººÏ   Æ®À§ÅÍ
 
Novo Cyte Quanteon Á¦Ç°»ó´ã¹®ÀÇ

Ư¡
  • ¿ÏÀü ÀÚµ¿È­µÈ ¼¼Ã´ ¹× Áß´Ü ±â´ÉÀ¸·Î °£ÆíÇÏ°Ô ÀÛµ¿
  • NovoSampler Q¸¦ ÅëÇÑ È¿À²ÀûÀÎ ¹«ÀÎ ¿î¿µ ÀÚµ¿È­
  • À¯¿¬ÇÑ ½Ã·á 󸮴 ¸Å¿ì ÀûÀº ¾ç¿¡¼­µµ È¿À²ÀûÀΠȥÇÕÀ» Á¦°øÇÏ°í, °¡Àå ´ëÁßÀûÀÎ Ç÷¹ÀÌÆ® Æ÷¸Ë, ¹ÙÄÚµå ÀÔ·Â ¹× ½ÇÇè½Ç ÀÚµ¿È­ ½Ã½ºÅÛÀ» À§ÇÑ ³»Àå API¸¦ ¼ö¿ëÇÕ´Ï´Ù.
  • »ç¿ëÀÌ °£ÆíÇÑ NovoExpress ¼ÒÇÁÆ®¿þ¾î´Â ÀÚµ¿ º¸¿Ï ±â´É, ¼¼Æ÷ Áֱ⠺м® ¸ðµâ, ¼¼Æ÷ Áõ½Ä ¸ðµâ, È÷Æ® ¸Ê ¹× ¹èÄ¡ Åë°è ºÐ¼® ±â´É µîÀ» °®Ãß°í ÀÖ½À´Ï´Ù.
»ç¾ç¼­
±Ô°Ý(WxDxH)
  • 62 cm x 46 cm x 48 cm
±íÀÌ
  • 46 cm
³ôÀÌ
  • 48 cm
·¹ÀÌÀú ±¸¼º
  • º¸¶ó»ö/ÆĶõ»ö/³ë¶õ»ö/»¡°£»ö
·¹ÀÌÀú ¼ö
  • 4
·¹ÀÌÀú ÆÄÀå
  • 405 nm
  • 488 nm
  • 561 nm
  • 637 nm
¹«°Ô
  • 47 kg
»ùÇøµ Æ÷¸Ë
  • 12 x 75mm Æ©ºê
  • 1.5mL Æ©ºê
  • 2mL Æ©ºê
Æø
  • 62 cm
Çü±¤ ä³Î
  • 16
  • 20
  • 25
»ç¿ë ¹æ¹ý

ÃÖ°íÀÇ ±¤°ËÃâ±â

½Ç¸®ÄÜ ±¤ÀüÀÚ Áõ¹è°ü(SiPM)Àº °íü»ó, ½Ç¸®ÄÜ ±âÆÇ ±â¹ÝÀÇ ±¤ÀÚ ¼öÁØÀÇ °¨µµ ¹ÝµµÃ¼ ÀåÄ¡·Î, 7.2 ·Î±×ÀÇ ÃøÁ¤ ¹üÀ§¸¦ Á¦°øÇÕ´Ï´Ù. µ¿½Ã¿¡ ÀÛµ¿ÇÏ´Â ÄÞÆÑÆ®ÇÑ ¾Ö¹ú·£Ä¡ ±¤ ´ÙÀÌ¿Àµå ¾î·¹ÀÌ·Î ±¸¼ºµÈ SiPMÀº ±¤Ä«¿îÆà ±â´ÉÀÌ ÀÖ´Â ¼ÒÇü °ËÃâ±âÀÔ´Ï´Ù. NovoCyte Quanteon¿¡ ¼³°èµÈ Çõ½ÅÀûÀÎ ±¤ÇÐ ÀåÄ¡´Â 25°³ÀÇ µ¶¸³ÀûÀÎ SiPMÀ» ÅëÇÕÇÏ¿© °¢ Çü±¤ ä³Î¿¡¼­ ½ÅÈ£¸¦ ȹµæÇÏ°í ó¸®ÇÕ´Ï´Ù.

ÀÛÀº ÀÔÀÚ¸¦ °ËÃâÇÏ´Â ¿ì¼öÇÑ »ê¶õ ºÐÇØ´É

NovoCyte Quanteon »ê¶õ °ËÃâ ±¤ÇÐ ÀåÄ¡ ¹× ½ÅÈ£ ó¸® ÀåÄ¡´Â ÀÔÀÚ Å©±â¸¦ 0.1¥ìm±îÁö ºÐ¼®Çϵµ·Ï ÃÖÀûÈ­µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ì¼öÇÑ ºÐÇØ´ÉÀ¸·Î Ç÷¼ÒÆÇ, ¹ÚÅ׸®¾Æ ¹× ´Ù¾çÇÑ Ãʹ̼¼ ÀÔÀÚ¸¦ ½±°Ô ½Äº°ÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù.


³ôÀº ÀçÇö¼º°ú ¾ÈÁ¤¼º

QuanteonÀÇ À¯Ã¼ ½Ã½ºÅÛÀº ¶Ù¾î³­ ¼º´ÉÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ´Ù¸¥ À¯¼¼Æ÷ ºÐ¼®±â¿Í ºñ±³ÇÒ ¶§ QuanteonÀÇ À¯Ã¼ ÀÏ°ü¼º ¹× ¾ÈÁ¤¼ºÀº ŸÀÇ ÃßÁ¾À» ºÒÇãÇÕ´Ï´Ù. ¿¬µ¿ ÆßÇÁ¸¦ »ç¿ëÇÏ´Â ´Ù¸¥ ±â±â´Â Á¾Á¾ À¯Ã¼ ¸Æµ¿ÀÇ ¿µÇâÀ» ¹Þ¾Æ Àý´ë ¼¼Æ÷ ¼ö¿¡¼­ ºÒÀÏÄ¡¿Í ºÎÁ¤È®¼ºÀ» ÃÊ·¡Çϱ⵵ ÇÕ´Ï´Ù.
 

ÀÀ¿ë ºÐ¾ß

¼¼Æ÷ »ç¸ê ºÐ¼®

¼¼Æ÷ »ç¸ê ¶Ç´Â ¼¼Æ÷¿¹Á¤»ç(programmed cell death)´Â ¼¼Æ÷°¡ Á×´Â ¹æ½ÄÀ» Á¶ÀýÇÏ´Â °úÁ¤À¸·Î ¼¼Æ÷¸¦ ¼öÃà, ÀÀÃàÇÏ°Ô Çϴ ƯÁ¤ °æ·Î¸¦ È°¼ºÈ­ÇÏ¿© °á°úÀûÀ¸·Î ½Ä¼¼Æ÷ÀÛ¿ë¿¡ ÀÇÇØ Á¦°ÅµË´Ï´Ù. ÀÌ´Â ÅëÁ¦ÇÒ ¼ö ¾øÀÌ Á׾ ºÐ¿­µÇ¾î ¸é¿ª ¹ÝÀÀÀ» È°¼ºÈ­½ÃÅ°´Â À¯ÇØÇÑ ¿µÇâÀ» ÃÊ·¡ÇÏ´Â ±«»ç ¼¼Æ÷ Á×À½°ú ¶Ñ·ÇÇÑ Â÷À̸¦ º¸¿©ÁÝ´Ï´Ù. µû¶ó¼­ »ç¸ê ¼¼Æ÷´Â ¸Å¿ì Áú¼­ÀÖ´Â ¹æ½ÄÀ¸·Î Á׾ ºÎ±ÙÀÇ ¼¼Æ÷¿Í Á¶Á÷ Æı«¸¦ ¸·¾Æ ÁÝ´Ï´Ù.

¼¼Æ÷ Á×À½À» ÃøÁ¤ÇÏ°í ¼¼Æ÷ »ç¸ê ¶Ç´Â ±«»ç¸¦ ±¸º°ÇÏ´Â ´Ù¾çÇÑ ¹æ¹ýÀÌ ÀÖ½À´Ï´Ù. ÀÚµ¿ º¸Á¤ ¼³Á¤ ¹× ±¤¹üÀ§ÇÑ Çü±¤ °ËÃâ ÃøÁ¤ ¹üÀ§¸¦ °¡Áø NovoCyte À¯¼¼Æ÷ ºÐ¼®±â¸¦ »ç¿ëÇϸé PMT Àü¾Ð Á¶ÀýÀÌ ÇÊ¿ä ¾øÀÌ ÀÌ·¯ÇÑ ºÐ¼®¿¡ ´ëÇÑ °£ÆíÇÑ Á¤·®ÀÌ °¡´ÉÇÕ´Ï´Ù.
 

¸é¿ª Ç¥ÇöÇü

¸é¿ª »óÅ´ Áúº´ »óÅÂ, Ä¡·á È¿À²¼º ¹× ¹é½Å°ú °°Àº ¿ÜºÎ Àڱؿ¡ ´ëÇÑ ¹ÝÀÀ°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¸é¿ª Ç¥ÇöÇü ºÐ¼®À¸·Î Èĺ¸ ¼¼Æ÷ À¯Çü, ÇÏÀ§ µî±Þ ¹× ±â´ÉÀ» ½Å¼ÓÇÏ°Ô ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸é¿ª ¼¼Æ÷´Â ¹é½ÅÀÇ ¸é¿ª¿ø¼º°ú ±× È¿À²¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¹Ç·Î ´Ù¾çÇÑ ¸é¿ª ¼¼Æ÷ Áý´ÜÀÇ ºóµµ¿Í ´ÜÇÙ±¸, NK ¼¼Æ÷, T¿Í B ¼¼Æ÷ °°Àº ƯÁ¤ ¼¼Æ÷ ÇÏÀ§ ÁýÇÕÀÇ ºÐÈ­ ¹× È°¼ºÈ­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. NovoCyte À¯¼¼Æ÷ ºÐ¼®±â´Â ¿©·¯ ¹éÇ÷±¸¸¦ µ¿½Ã¿¡ Á¤·®ÇÒ ¼ö ÀÖ¾î ȯÀÚÀÇ ¸é¿ª »óŸ¦ º¸´Ù Àß ÀÌÇØÇÏ°í Àü¿°¼º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀ» °¨½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ¼¼È÷ ¾Ë¾Æº¸±â >


¼¼Æ÷³» ´Ü¹éÁú °ËÃâ

¼¼Æ÷³» ´Ü¹éÁúÀÇ °ËÃâ ¹× ºÐ¼®À» ÅëÇØ ¼¼Æ÷ ÇÏÀ§ Áý´Ü ¹× ¼¼Æ÷ °úÁ¤¿¡ ´ëÇÑ Ãß°¡ÀûÀΠƯ¼º ±Ô¸íÀÌ °¡´ÉÇÕ´Ï´Ù. ¼¼Æ÷ Ç¥¸é¿¡ ÀÖÁö ¾ÊÀº ´Ü¹éÁúÀ» ºÐ¼®ÇÏ·Á¸é ¼¼Æ÷ °íÁ¤ ¹× Åõ°úÈ­¸¦ °ÅÃÄ¾ß ÇÕ´Ï´Ù. ±×·¯³ª ¸¹Àº ÀλêÈ­ ƯÀÌÀûÀÎ Ç×ü´Â ¼¼Æ÷³» ¿°»ö¿¡ »ç¿ëµÇ´Â ÀϹÝÀûÀÎ ¼¼Ã´¾× ±â¹Ý Åõ°úÈ­ ¹æ¹ý°ú ȣȯµÇÁö ¾Ê½À´Ï´Ù. ÀλêÈ­ ƯÀÌÀûÀÎ Ç×ü¿¡ ´ëÇÑ ÀûÀýÇÑ °íÁ¤ ¹× Åõ°úÈ­ ¹æ¹ýÀ» °áÁ¤ÇÒ ¶§ Ưº°ÇÑ ÁÖÀÇ°¡ ÇÊ¿äÇÕ´Ï´Ù. °¡Àå ÀϹÝÀûÀÎ ¹æ¹ýÀº °íÁ¤ ½Ã 1.5% ÆĶóÆ÷¸§¾Ëµ¥È÷µå¸¦ »ç¿ëÇÑ ´ÙÀ½ Åõ°úÈ­¸¦ À§ÇØ 100% ¸Þź¿ÃÀ» »ç¿ëÇÕ´Ï´Ù. ÀÌ ¹æ¹ýÀº ¸¹Àº Ç×ü¿¡ Àû¿ëÇÒ ¼ö ÀÖÁö¸¸ ¸ðµç ÀλêÈ­ ƯÀÌÀûÀÎ Ç×ü¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Õ´Ï´Ù.

¶ÇÇÑ, ºñµ¿Áú¼º ½Ã·á¿¡¼­ ´Ù¾çÇÑ ¼¼Æ÷ Áý´ÜÀ» ½Äº°ÇÏ·Á¸é Ç¥¸éÀÇ ´Ü¹éÁú°ú °áÇÕµÈ ÀλêÈ­ ´Ü¹éÁúÀ» ¿°»öÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿¡ÇÇÅäÇÁÀÇ °íÁ¤Á¦¿¡ ´ëÇÑ ¹Î°¨¼ºÀ» Ưº°È÷ ÁÖÀǸ¦ ±â¿ï¿©¾ß Çϸç, ¿¡ÇÇÅäÇÁ¸¦ ¼Õ»ó½ÃÅ°Áö ¾Êµµ·Ï ¿¹¹æÁ¶Ä¡¸¦ ÃëÇØ¾ß ÇÕ´Ï´Ù. µû¶ó¼­ °íÁ¤ Àü¿¡ ƯÁ¤ Ç¥¸é ¸¶Ä¿¿¡ ´ëÇØ ½Ã·á¸¦ ¹Ì¸® ¿°»öÇØ¾ß ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ¼¼È÷ ¾Ë¾Æº¸±â >


¼¼Æ÷ Áֱ⠺м®

Á¤»óÀûÀÎ Àΰ£ ü¼¼Æ÷´Â ÀÏÁ¤ÇÑ ¾çÀÇ DNA¸¦ Æ÷ÇÔÇÏ´Â À̹èüÀÔ´Ï´Ù. ¼¼Æ÷ ÁֱⰡ ÁøÇàµÇ´Â µ¿¾È DNA ÇÕ¼ºÀ¸·Î Àüü DNA ÇÔ·®ÀÌ µÎ ¹è·Î ´Ã¾î³ª°í À¯»ç ºÐ¿­ ÈÄ Á¤»óÀûÀÎ DNA ÇÔ·®À» ȸº¹ÇÕ´Ï´Ù. NovoCyte À¯¼¼Æ÷ ºÐ¼®±â¸¦ »ç¿ëÇÏ¸é »ó¼¼ÇÑ ¼¼Æ÷ Áֱ⠺м®À» ¼öÇàÇÏ¿© Á¾¾ç ¼¼Æ÷ ºÐÈ­, ¼¼Æ÷ º¯Çü ¹× ¼¼Æ÷ È­ÇÕ¹° °£ÀÇ »óÈ£ ÀÛ¿ëÀ» ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

±×¸²: 10µg/M MG132 ¶Ç´Â 500µg/M 5-FU·Î 16½Ã°£ ó¸®ÇÑ ÈÄ, ACEA NovoCyte À¯¼¼Æ÷ ºÐ¼®±â·Î A549 ¼¼Æ÷ÀÇ ¼¼Æ÷ Áֱ⠺ÐÆ÷¸¦ ºÐ¼®Çß½À´Ï´Ù. NovoExpress¿¡ Æ÷ÇÔµÈ ¼¼Æ÷ Áֱ⠺м® ¸ðµâÀ» »ç¿ëÇϸé Ç÷Կ¡ G0/G1 ´Ü°è(³ì»ö), S ´Ü°è(³ë¶õ»ö) ¹× G2/M ´Ü°è(ÆĶõ»ö)ÀÇ ¼¼Æ÷°¡ Ç¥½ÃµË´Ï´Ù. ÀÏ¹Ý ¹Ìó¸® ¼¼Æ÷¿Í ºñ±³ÇÏ¿© MG132 ó¸® ¼¼Æ÷´Â G2/M ´Ü°è¿¡¼­ Á¤ÁöµÈ ¹Ý¸é 5-FU ó¸® ¼¼Æ÷´Â G0/G1 ´Ü°è¿¡¼­ Á¤ÁöµÇ¾ú½À´Ï´Ù.

ÀÚ¼¼È÷ ¾Ë¾Æº¸±â >


¼¼Æ÷ Áõ½Ä

¼¼Æ÷ Áõ½ÄÀº Çʼö ±â´ÉÀ̸ç Á¶ÀýµÇÁö ¾ÊÀ» °æ¿ì Áúº´À» À¯¹ßÇÒ ¼ö ÀÖ´Â °íµµ·Î ±¸Á¶È­µÈ À̺¥Æ®ÀÔ´Ï´Ù. Àý´ë ¼¼Æ÷ ¼ö ¶Ç´Â CFSE¿Í °°Àº ¿°·á·Î Áõ½ÄÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. CFSE·Î ¶óº§¸µµÈ ¼¼Æ÷°¡ ºÐÇÒµÉ ¶§, ¿°·á´Â µþ¼¼Æ÷ »çÀÌ¿¡¼­ ±ÕµîÇÏ°Ô ºÐÇÒµÇ°í ¿°·á°¡ Áö¼ÓÀûÀ¸·Î Èñ¼®µÊ¿¡ µû¶ó ½Ã°£¿¡ µû¸¥ CFSE Çü±¤ ¼Õ½ÇÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿°·áÀÇ Æò±Õ Çü±¤ °­µµ(MFI)¸¦ ½Ã°£¿¡ µû¸¥ ¼¼Æ÷ ³óµµ·Î Ç÷ÔÇÏ¿© µÑ »çÀÌÀÇ ¹Ýºñ·Ê °ü°è¸¦ ³ªÅ¸³À´Ï´Ù. ÀÌ·¯ÇÑ À¯ÇüÀÇ ºÐ¼®Àº Á¾Á¾ T ¸²ÇÁ±¸ È°¼ºÈ­ÀÇ º¯È­¸¦ °üÂûÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

 
±×¸²: CFSE¸¦ »ç¿ëÇÑ Jurkat T ¼¼Æ÷ÀÇ Áõ½Ä ÃøÁ¤. A) Jurkat T ¼¼Æ÷¸¦ CFSE·Î ¶óº§¸µÇÏ°í NovoCyte À¯¼¼Æ÷ ºÐ¼®±â¿¡¼­ ½Ã°£ °æ°ú¿¡ µû¸¥ ¼¼Æ÷ ºÐ¿­À» ÃøÁ¤ÇÏ¿© ºÐ¼®ÇÕ´Ï´Ù. °¢ ÇÇÅ©´Â °³º° ½ÃÁ¡À» ³ªÅ¸³À´Ï´Ù. B) ¼¼Æ÷°¡ ºÐ¿­ÇÒ ¶§ »ý¼ºµÈ ½ÅÈ£ÀÇ Èñ¼®À» »ç¿ëÇÏ¿© ½Ã°£ °æ°ú¿¡ µû¸¥ CFSEÀÇ Æò±Õ Çü±¤ °­µµ(MFI)¸¦ ÃøÁ¤ÇÏ´Â ÇÑÆí, Àý´ë ¼¼Æ÷ ¼ö¸¦ ³ªÅ¸³À´Ï´Ù.
 

ÀÚ·á
ÀÀ¿ë ÀÚ·á

Ex Vivo Phenotyping and Potency Monitoring of CD19 CAR T Cells: Using a combined flow cytometry and impedance‑based real-time cell analysis workflow

To efficiently determine optimal CAR construction, researchers must develop a robust screening protocol to identify the evaluate cells and cytokytic potency. Here, we describe a workflow using a combination of the Agilent xCELLigence RTCA analyzer and Agilent NovoCyte Quanteon flow cytometer to thoroughly evaluate and characterize CAR T cells.

Detection of Rare Cells and Circulating Tumor Cells using Flow Cytometric Methods

A tumor cell spiking assay was performed to determine the sensitivity and accuracy of rare cell detection on the Agilent NovoCyte Quanteon flow cytometer.

Sentinel Panel Design of 16-Color, 28-Markers for Immunophenotyping Peripheral Human Whole Blood

Using a sentinel panel design, a 16-color panel using 28 different antibodies can be designed for the three-laser Agilent NovoCyte Advanteon flow cytometer.

Comprehensive 18-Color Pan-Leukocyte Flow Cytometry Analysis for Immune Surveillance

A description of an 18-color immunophenotyping stain being used to examine leukocyte subsets in human peripheral blood mononuclear cells (PBMCs).

µ¥ÀÌÅÍ ½ÃÆ®
Áö¿ø
¼³¸í ½ÃÆ®

Dell Ownership Transfer Process

Dell Ownership transferring process

Åø

SpectraViewer µµ±¸

Spectra Viewer µµ±¸¸¦ »ç¿ëÇÏ¿© À¯¼¼Æ÷ ºÐ¼®±â¿Í ȣȯ °¡´ÉÇÑ Çü±¤»ö¼Ò¸¦ ã¾Æº¸¼¼¿ä

 

FluoroFinder Panel Builder

½ÇÇèÀ» À§ÇØ ´Ù»ö Ç×ü ÆгÎÀ» ¸¸µå´Â µ¥ µµ¿òÀÌ ÇÊ¿äÇϼ¼¿ä? FluoroFinder Panel Builder¸¦ »ç¿ëÇØ º¸¼¼¿ä!

 

Quanteon À¯¼¼Æ÷ ºÐ¼®±â ½Ã½ºÅÛ¿¡ ´ëÇÑ ¸®ºä¸¦ Àо¼¼¿ä

SelectScience¿¡ °ÔÀçµÈ °í°´ ¸®ºä ã¾Æº¸±â

ºñµð¿À

1 - 3 ÀÇ 5 °á°ú

¸Ç À§·Î 
°ü·Ã Á¦Ç°
Example category image description

NovoSampler Q

NovoCyte Quanteon ¹× NovoCyte AdvanteonÀ¸·Î À¯¼¼Æ÷ ºÐ¼® ÀÚµ¿È­ ¼Ö·ç¼Ç ¿Ï¼º

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼®±â